These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12397935)

  • 1. [Effect of peripheral opiate receptor agonist dalargin on exercise tolerance in patients with coronary and peripheral arteries atherosclerosis].
    Maslov LN; Fedorova NA; Dudko VA; Karpov RS
    Fiziol Cheloveka; 2002; 28(5):81-7. PubMed ID: 12397935
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical response to agonists of mu and beta opiate receptors in patients with ischemic heart disease: effects of D-Ala2-Leu5-Arg6-enkephalin on hemodynamics, oxygen balance and lipid spectrum of blood].
    Maslov LN; Sokolov AA; Fedorova NA; Lishmanov IuB; Karpov RS
    Klin Med (Mosk); 2002; 80(8):53-7. PubMed ID: 12360622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanism of the action of dalargin in experimental myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Glushchenko NV; Semushkina TM
    Biull Eksp Biol Med; 1992 Oct; 114(10):345-7. PubMed ID: 1288681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
    Dudko VA; Fedorova NA; Didenko VA; Zoloev GK
    Sov Med; 1990; (2):90-2. PubMed ID: 2192476
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathophysiological and clinical evaluation of the effectiveness of dalargin in the treatment of arterial occlusive diseases of the lower extremities].
    Zoloev GK; Dudko VA; Sokolovich GE; Poiarkov VD; Ponurovskiĭ ; Beloglazov ME; Ivatsin NP; Stepanian NA; Shil'nikov MG
    Kardiologiia; 1990 Jul; 30(7):77-9. PubMed ID: 2232471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular effects of D-ALA2, LEU5, ARG6-enkephalin (dalargin) are mediated by peripheral mu-opioid receptor activation].
    Maslov LN; Lishmanov IuB; Barzakh EI; Maksimov IV; Vorozgtsova IN; Bukhovets IL; Minin SM; Orlova EB; Lavrov AG; Ovchinnikov MV
    Eksp Klin Farmakol; 2008; 71(2):21-8. PubMed ID: 18488902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanism of the antiarrhythmic action of dalargin in experimental myocardial ischemia].
    Maslov LN; Lishmanov IuB
    Eksp Klin Farmakol; 1992; 55(2):25-8. PubMed ID: 1358376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-functional characteristics of patients with arteriosclerosis obliterans of the lower extremities and painless myocardial ischemia].
    Volkov VS; Beliaeva GS
    Kardiologiia; 1990 Jul; 30(7):74-6. PubMed ID: 2232470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of synthetic analogs of enkephalins as antiatherogenic means].
    Zoloev GK; Slepushkin VD; Argintaev ES; Prum IA; Sokolovich GE
    Biull Eksp Biol Med; 1989 Oct; 108(10):468-70. PubMed ID: 2597763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of dalargin on the hemodynamics in acute myocardial infarct complicated by clinical death].
    Lisachenko GV; Slepushkin VD; Zoloev GK
    Anesteziol Reanimatol; 1992; (4):57-9. PubMed ID: 1485679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of dalargin and des-Tyr-dalargin on the functional state of intact and ischemized-reperfused myocardium].
    Lasukova TV; Maslov LN; Lishmanov IuB; Ovchinnikov MV; Bespalova ZhD; Podoksenov IuK; Podoksenov AIu
    Eksp Klin Farmakol; 2004; 67(4):21-5. PubMed ID: 15500040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The restriction of hemodynamic disorders in acute hypoxia and in situ reoxygenation by using the synthetic peptide bioregulator dalargin].
    Pashutin SB
    Biull Eksp Biol Med; 1991 Nov; 112(11):505-7. PubMed ID: 1810489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proof of stimulating effect of dalargin of the process of cell division through opiate receptors].
    Pan'kova TD; Timoshin SS
    Biull Eksp Biol Med; 1990 Jul; 110(7):96-8. PubMed ID: 2171699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of opiate peptide dalargin and des-Tyr-dalargin on cardiac pump function during ischemia-reperfusion.
    Lasukova TV; Maslov LN; Podoksenov YK; Podoksenov AY; Platonov AA; Ovchinnikov MV; Bespalova ZhD
    Bull Exp Biol Med; 2004 Jan; 137(1):27-30. PubMed ID: 15085238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of dalargin on hemodynamics of anesthesized rats during truncal vagotomy].
    Donich SG; Smirnova VI; Likhvantsev VV; Buglak NP; Svirgunenko IuP
    Biull Eksp Biol Med; 1991 Jun; 111(6):622-3. PubMed ID: 1893189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of using dalargin electrophoresis in the combined treatment of patients with ischemic heart disease].
    Ilaev TM; Ratner ZG
    Lik Sprava; 1998; (2):74-7. PubMed ID: 9670662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of dalargin on the course of myocardial ischemia].
    Mikhaĭlova SD; Semushkina TM; Bebiakova NA
    Kardiologiia; 1991 Jan; 31(1):13-5. PubMed ID: 2046237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioimmunologic and radioreceptor studies of the pharmacokinetics of the enkephalin analog dalargin in man].
    Zaĭtsev SV; Vinogradov VA; Sergeeva MG; Dmitrieva OF; Ivanikov IO
    Biull Eksp Biol Med; 1986 Jun; 101(6):702-4. PubMed ID: 3730557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Participation of central and peripheral mu- and delta opiate receptors in anti-arrhythmia action of enkephalins].
    Maslov LN; Lishmanov IuB
    Biull Eksp Biol Med; 1991 Aug; 112(8):124-6. PubMed ID: 1664748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of dalargin in the intensive therapy of critical conditions].
    Smirnova VI; Pulina NN; Kazennov VV; Oranskiĭ AV; Smirnov EP
    Vestn Ross Akad Med Nauk; 1994; (6):48-51. PubMed ID: 7522704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.